GlassScriptPhysician profile
Christopher James Kallinger
NPI 1720520687
$15,698.05
in general payments reported to CMS, 2019-2025
50 companies · $4,708 in 2025
The $4,708 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,461 · 2022: $1,825 · 2023: $3,418 · 2024: $4,286 · 2025: $4,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,884.00 |
| Education | $528.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,979.97 | 2021-2025 | |
| Amgen INC. | $1,855.90 | 2021-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $1,228.79 | 2022-2025 | Ilumya |
| Leo Pharma INC. | $974.38 | 2022-2025 | Adbry, Anzupgo, Spevigo |
| Incyte Corporation | $818.64 | 2022-2025 | Opzelura |
| Pfizer INC. | $799.55 | 2021-2025 | |
| Lilly USA, LLC | $736.27 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $703.93 | 2022-2025 | Tremfya, Stelara, Remicade |
| Ucb, INC. | $661.44 | 2023-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $652.20 | 2022-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $590.84 | 2021-2025 | |
| Genzyme Corporation | $500.83 | 2022-2025 | |
| Organogenesis INC. | $439.07 | 2023-2025 | Affinity, Novachor, Simplimax |
| E.R. Squibb & Sons, L.L.C. | $397.06 | 2023-2025 | Sotyktu, Sprycel |
| Esperion Therapeutics, INC. | $313.13 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kallinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.